Adjuvant arthritis-induced changes on ampicillin binding in serum and tissues under the influence of non-steroidal anti-inflammatory drugs in rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 30, Issue 4, 2005, Pages 235-241

  Tigka, E ^a   Daskala, I ^a   Rallis, G ^b   Anagnostopoulou, S ^a   Tesseromatis, Christine ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Ampicillin binding; Arthritis; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; FLURBIPROFEN; IBUPROFEN; KETOPROFEN; LIVER PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; PLASMA PROTEIN; SERUM ALBUMIN;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BINDING; DRUG CLEARANCE; DRUG INDUCED DISEASE; JOINT DESTRUCTION; NONHUMAN; PKA; RAT; RECEPTOR AFFINITY; RHEUMATOID ARTHRITIS;

EID: 30744448659     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190626     Document Type: Article

References (39)

1. Mirshafiey A, Cuzzocrea S, Rehm B, Mazzon E, Saadat F, Sotoude M (2005): Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug. Scand J Immunol 61(5):435-441.
2. Kvien TK (2004): Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22(Suppl 2):1-12.
3. Dorner T, Egerer K, Feist E, Burmester GR (2004): Rheumatoid factor revisited. Curr Opin Rheumatol 16(3):246-253.
4. Walker JS, Kasmerski L (1988): Diflunisal pharmacodynamics in experimental arthritis in rats. J Rheumatol 15(11):1643-1647.
5. Barre J, Houin G, Brunner F, Bree F, Tillement JP (1983): Disease-induced modifications of drug pharmacokinetics. Int J Clin Pharmacol Res 3(4):215-226.
6. Yamasaki K, Rahman MH, Tsutsumi Y, Maruyama T, Ahmed S, Kragh-Hansen U, et al. (2999): Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS Pharm Sci Tech 1(2): 12.
7. Verbeeck RK, Blackburn JL, Loewen GR (1983): Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 8(4):297-331.
8. McElnay JC, D'Arcy PF (1983): Protein binding displacement interactions and their clinical importance. Drugs 25(5):495-513.
9. Verbeeck RK (1990): Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet 19(1):44-66.
10. Mourouzis C., Saranteas T, Tsamouris M, Tesseromatis C (2003): Morphological changes of parotid glands following adjuvant arthritis and ibuprofen treatment in rats. Int J Oral Maxillofac Surg 32(1):69-73.
11. Trichilis A, Saranteas T, Potamianou A, Mourouzis C, Tesseromatis C (2003): Quinolone levels in serum and maxillofacial tissues under ibuprofen co-administration following surgical trauma. J Musculoskelet Neuronal Interact 3(2):170-175.
12. Saranteas T, Mourouzis C, Dannis C, Alexopoulos C, Lolis E, Tesseromatis C (2004): Effect of various stress models on lidocaine pharmacokinetic properties in the mandible after masseter injection. J Oral Maxillofac Surg 62(7):858-862.
13. Craig WA, Welling PG (1977): Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2(4):252-268.
14. Tesseromatis C, Trichilis A, Tsivos E, Messari J, Triantaphyllidis H, Varonos DD (2001): Does stress influence ampicillin concentration in serum and tissues? Eur J Drug Metab Pharmacokinet 26(3):167-171.
15. Trichilis A, Tesserommatis C, Varonos D. (2000): Changes in serum levels of quinolones in rats under the influence of experimental trauma. Eur J Drug Metab Pharmacokinet 25(2):73-78.
16. Committee on Care and Use of Laboratory Animals (1985): Guides for the care and use of laboratory animals. Washington, DC: Institute of Laboratory Animals and Resources. National Research Council, p. 83.
17. Tesseromatis C, Kurz H, Fichtl B (1987): Binding of non-steroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro. Eur J Drug Metab Pharmacokinet 12:161-167.
18. Bennet VJ, Broide LJ, Benner LE, Kirby NW (1966): Simplified accurate method for antibiotic assay of clinical specimens. Appl Microbiol 14:170-177.
19. Powis G (1974): A study of the interaction of tetracycline with human serum lipoproteins and albumin. J Pharm Pharmacol 26(2):113-118.
20. Craig WA, Kunin CM (1976): Significance of serum protein and tissue binding of antimicrobial agents. Annu Rev Med 27:287-300.
21. Kunin CM (1964): Enhancement of antimicrobial activity of penicillins and other antibiotics in human serum by competitive serum binding inhibitors. Proc Soc Exp Biol Med 117:69-73.
22. Needs CJ, Brooks PM (1985): Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 10(2):164-177.
23. Craig WA, Suh B (1978): Changes in protein binding during disease. Scand J Infect Dis Suppl(14):239-244.
24. Agapitova IV, Iakovlev VP (1987): [Antibiotic pharmacokinetics in rats with an infected inflammation]. Antibiot Med Biotekhnol 32(7):508-511.
25. Craig WA, Ebert SC (1989): Protein binding and its significance in antibacterial therapy. Infect Dis Clin North Am 3(3):407-414.
26. Wise R (1986): The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clin Pharmacokinet 11(6):470-482.
27. Guirguis MS, Jamali F (2003): Disease-drug interaction: reduced response to propranolol despite increased concentration in the rat with inflammation. J Pharm Sci 92(5):1077-1084.
28. Weismeier K, Adam D, Heilmann HD, Koeppe P (1989): Penetration of amoxycillin/clavulanate into human bone. J Antimicrob Chemother 24(SupplB):93-100.
29. Iwamoto J, Yeh JK, Aloia JF (2000): Effect of deconditioning on cortical and cancellous bone growth in the exercise trained young rats. J Bone Miner Res 15(9):1842-1849.
30. Brooker DS (1988): Rheumatoid arthritis: otorhinolaryngological manifestations. Otolaryngol Clin North Am.
31. Jiang G, Matsumoto H, Yahane J, Kuboyama N, Akimoto Y, Fujii A (2004): Prevention of trabecular bone loss in the mandible of ovariectomized rats. J Oral Sci 46: 75-85.
32. Incavo SJ, Ronchetti PJ, Choi JH, Wu H, Kinzig M, Sorgel F (1994): Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues. Antimicrob Agents Chemother 38(4):905-907.
33. Djabarouti S, Boselli E, Allaouchiche B, Ba B, Nguyen AT, Gordien JB, et al. (2004): Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J Chromatogr B Anal Technol Biomed Life Sci 799(1):165-172.
34. Tomoda K, Kitaoka M, Iyama K, Usuku G (1986): Endosteal new bone formation in the long bones of adjuvant treated rats. Pathol Res Pract 181(3):331-338.
35. Hara T, Tanck E, Homminga J, Huiskes R (2002): The influence of microcomputed tomography threshold variations on the assessment of structural and mechanical trabecular bone properties. Bone 31(1):107-109.
36. Hand DR, Watkins JP, Honnas CM, Kemper D (2001): Osteomyelitis of the sustentaculum tali in horses: 10 cases (1992-1998). J Am Vet Med Assoc 219(3):341-345.
37. Van den Hoven R, Hierweck B, Dobretsberger M, Ensink JM, Meijer LA (2003): Intramuscular dosing strategy for ampicillin sodium in horses, based on its distribution into tissue chambers before and after induction of inflammation. J Vet Pharmacol Ther 26(6):405-411.
38. Errecalde JO, Carmely D, Mariño EL, Mestorino N (2001): Pharmacokinetics of amoxycillin in normal horses and horses with experimental arthritis. J Vet Pharmacol Ther 24(1):1.
39. Goldstein R, Lavy E, Shem-Tov M, Glickman A, Bark H, Ziv G (1995): Pharmacokinetics of ampicillin administered intravenously and intraosseously to kittens. Res Vet Sci 59(2):186-187.